Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) EBT Margin (2019 - 2025)

Historic EBT Margin for aTYR PHARMA (ATYR) over the last 6 years, with Q3 2025 value amounting to 14076.32%.

  • aTYR PHARMA's EBT Margin changed N/A to 14076.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 41395.26%, marking a year-over-year decrease of 124365400.0%. This contributed to the annual value of 28899.57% for FY2024, which is 133417800.0% down from last year.
  • Latest data reveals that aTYR PHARMA reported EBT Margin of 14076.32% as of Q3 2025.
  • In the past 5 years, aTYR PHARMA's EBT Margin ranged from a high of 76.55% in Q4 2022 and a low of 14076.32% during Q3 2025
  • Over the past 4 years, aTYR PHARMA's median EBT Margin value was 5326.4% (recorded in 2024), while the average stood at 6201.42%.